percent

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

1 month ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

1 month ago

XRP News: Vaultro Finance Presale on XRP Ledger Sells Past 48% of Its Native Token Allocation Act Now Before It Sells Out

SINGAPORE, June 14, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has once again smashed expectations, announcing that 48% percent of its…

1 month ago

Introducing FactsR by Corti — the First Clinical Reasoning Layer for Ambient AI in Healthcare

Real-time, recursive, fact-first architecture reduces AI-generated "note bloat" by 65 percent and minimizes post-visit edits - transforming passive documentation into…

2 months ago

Kia America Posts Eighth Consecutive Month of YearOverYear Sales Growth

79,007 units sold in May, a 5-percent increase compared to previous yearBest-ever May performances for Telluride, Sportage, Carnival, and K42026…

2 months ago

Kia Announces May 2025 Global Sales Results

May 2025 global sales of 269,148 units, up 1.7% Y/yOutside of Korea, Kia sold 223,817 units, up 2.6% Y/yKia SUVs…

2 months ago